Dynamic quotes: Off
|
ETFs with TMO as a Top 10 Holding*Sponsored by:
| Weighting | ETF Name (Symbol) | 100-Day Price Change (%) |
|---|---|---|
| 8.12% | iShares Dow Jones U.S. Medical Devices Index Fund (IHI) | +6.66 (9.02%) |
| 2.55% | PowerShares Dynamic Heathcare (PTH) | +6.05 (17.26%) |
| 1.97% | Guggenheim S&P 500 Equal Weight Healthcare ETF (RYH) | +11.62 (13.72%) |
| 1.3% | First Trust Value Line Equity Allocation Index(sm)Fund (FVI) | +2.73 (14.78%) |
| 1.05% | First Trust Large Cap Growth AlphaDEX Fund (based on the Defin (FTC) | +3.81 (12.03%) |
|
||
*Data is provided by Barchart.com. Data reflects weightings calculated at the beginning of each month. Data is subject to change.
**Green highlights the top performing ETF by % change in the past 100 days.
Company Description (as filed with the SEC)
Thermo Fisher Scientific Inc. (also referred to in this document as “Thermo Fisher,” “we,” the “company,” or the “registrant”) is the world leader in serving science. Our mission is to enable our customers to make the world healthier, cleaner and safer by providing analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. In November 2006, Thermo Electron Corporation (also referred to in this document as “Thermo,” which is the predecessor to Thermo Fisher) merged with Fisher Scientific International Inc. (also referred to in this document as “Fisher”) to create Thermo Fisher. Thermo Fisher has approximately 38,900 employees and serves more than 350,000 customers within pharmaceutical and biotech companies, hospitals and clinical diagnostic labs, universities, research institutions and government agencies, as well as environmental, industrial quality and process control settings. ... More ...
Analyst Info |
|
| Annual EPS Est: | $4.94 |
| Quarterly EPS Est: | 1.3 |
| PEG Ratio: | 1.55 |
|
Mean Recommendation: View Summary / View All |
1.04 |
Data is provided by Zacks Investment Research
